June 5, 2024
UPPSALA, Sweden -- Olink Holding AB (publ) (Nasdaq: OLK) today announced the introduction of Olink Target 48 Immune Surveillance, a validated multiplexed protein assay panel that offers a detailed view of the immune system for in-depth monitoring of inflammation and immune response in clinical research. More Confidence, More Insights, Less Sample Biomarker selection for Olink [...]
June 5, 2024
Increasing the Work Efficiency and Realizing Advanced Color Management by Improving Operability and Functionality Tokyo - Konica Minolta, Inc. (Konica Minolta) today announced that the Company will launch the CM-17d and CM-16d vertical, lightweight, portable spectrophotometers capable of high-accuracy measurement in any situation, in the summer of 2024. The CM-17d and CM-16d are the successor [...]
June 5, 2024
On April 1, Shimadzu acquired all shares of Zef Scientific Inc. (ZefSci,Headquarters: Orange County, California) through its U.S. subsidiary Shimadzu Scientific Instruments, Inc. (SSI).ZefSci is now a subsidiary of SSI.ZefSci provides maintenance and repair services, on liquid chromatographs (LC) and liquid chromatograph mass spectrometers (LC-MS). With the acquisition of ZefSci, Shimadzu will expand its after-sales [...]
June 5, 2024
Molecular Devices is the world’s only company offering a service to manufacture standardized, quality-tested patient-derived organoids at a scale of many millions per batch SAN JOSE, Calif., and CARDIFF, Wales – Today, Molecular Devices, LLC., a leading high-performance life science solutions provider, officially opened its custom-built site in Cardiff, UK. The multi-million-pound facility was custom-built for the [...]
Sphere Fluidics launches Cyto-CellectPLUS to accelerate cell line development workflows
June 4, 2024
Next-generation assay provides a rapid and cost-effective solution to quantify IgG production in single cells Cambridge, UK -- Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the launch of Cyto-Cellect®PLUS. In conjunction with the Company’s Cyto-Mine® platform, the new assay provides a streamlined method to measure antibody [...]
June 4, 2024
SAN DIEGO -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced that it has completed integration of its latest chemistry, XLEAP-SBS™, into all reagents for its NextSeq™ 1000 and NextSeq 2000 next-generation sequencing (NGS) instruments. "We are excited to deliver for our NextSeq 1000/2000 customers improved sequencing with faster run times, [...]
Beckman Coulter Life Sciences Releases Innovative Assay to Quantify Antibody Aggregation
June 4, 2024
INDIANAPOLIS – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, continues its mission to reduce workflow times and grueling manual steps with the launch of its new Valita Aggregation Pure assay. The plate-based 96-well screening tool offers rapid, high-throughput protein aggregation detection and quantification, providing robust aggregation data in as little as [...]
June 4, 2024
This unprecedented approach integrates genomic, proteomic, and clonotypic assessment of subclonal multiple myeloma and its precursor stages Late-breaking data on clonal tracking in smoldering to active myeloma progression presented at the European Hematology Association (EHA) show on June 14 SOUTH SAN FRANCISCO, Calif. -- Mission Bio, a leader in single-cell multi-omics solutions for precision medicine, [...]
Saguaro Biosciences Secures $3M in Seed Funding to Transform Cell Biology Research
June 4, 2024
Quebec City, Canada – Saguaro Biosciences, a pioneering developer of live cell reagents for AI-enhanced discoveries, today announced the successful closing of a $3 million seed funding round, comprised of equity investments and non-dilutive grant funding. The funding round was led by AQC Capital and Anges Québec, featuring significant contributions from notable figures including Martin [...]
MilliporeSigma Announces Siren Biotechnology as Winner of its North American Advance Biotech Grant
June 4, 2024
Siren Biotechnology to receive products, technologies and contract testing services to develop gene therapy treatments for cancer Experts from MilliporeSigma’s Emprove® team and M Lab™ Collaboration Center to provide consultation and training Company has awarded grants to 40-plus biotechnology companies since 2014 BURLINGTON, Mass. -- MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, [...]

